Evidence map›Paper›PMID 30577635›Full record

ArticleAntioxidants (Basel, Switzerland)2018

Suppression of Light-Induced Oxidative Stress in the Retina by Mitochondria-Targeted Antioxidant.

Viktoriia E Baksheeva, Veronika V Tiulina, Natalia K Tikhomirova, Olga S Gancharova, Sergey V Komarov, Pavel P Philippov, Andrey A Zamyatnin, Ivan I Senin, Evgeni Yu Zernii

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Antioxidants (Basel, Switzerland) · 2022
    Article
  11. Article
  12. Review
  13. Review
  14. Different Doses ofOxidative medicine and cellular longevity · 2021
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Viktoriia E BaksheevaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia. vbaksheeva@belozersky.msu.ru.
Veronika V TiulinaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia. tyulina_nika@list.ru.
Natalia K TikhomirovaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia. tikhomir@belozersky.msu.ru.
Olga S GancharovaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia. olgancharova@belozersky.msu.ru.
Sergey V KomarovDepartment of Biology and Pathology of Domestic, Laboratory and Exotic Animals, Skryabin Moscow State Academy of Veterinary Medicine and Biotechnology, Moscow 109472, Russia. skomarov1977@mail.ru.
Pavel P PhilippovBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia. ppph@belozersky.msu.ru.
Andrey A ZamyatninBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia. zamyat@genebee.msu.ru.
Ivan I SeninBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia. senin@belozersky.msu.ru.
Evgeni Yu ZerniiBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia. zerni@belozersky.msu.ru.
Lomonosov Moscow State University · RUSechenov University · RUMoscow State Academy of Veterinary Medicine and Biotechnology named after Skryabin · RU

Funding

Russian Science Foundation 16-15-00255
6 · The paper itself

Abstract

Light-induced oxidation of lipids and proteins provokes retinal injuries and results in progression of degenerative retinal diseases, such as, for instance, iatrogenic photic maculopathies. Having accumulated over years retinal injuries contribute to development of age-related macular degeneration (AMD). Antioxidant treatment is regarded as a promising approach to protecting the retina from light damage and AMD. Here, we examine oxidative processes induced in rabbit retina by excessive light illumination with or without premedication using mitochondria-targeted antioxidant SkQ1 (10-(6'-plastoquinonyl)decyltriphenyl-phosphonium). The retinal extracts obtained from animals euthanized within 1⁻7 days post exposure were analyzed for H₂O₂, malondialdehyde (MDA), total antioxidant activity (AOA), and activities of glutathione peroxidase (GPx) and superoxide dismutase (SOD) using colorimetric and luminescence assays. Oxidation of visual arrestin was monitored by immunoblotting. The light exposure induced lipid peroxidation and H₂O₂ accumulation in the retinal cells. Unexpectedly, it prominently upregulated AOA in retinal extracts although SOD and GPx activities were compromised. These alterations were accompanied by accumulation of disulfide dimers of arrestin revealing oxidative stress in the photoreceptors. Premedication of the eyes with SkQ1 accelerated normalization of H₂O₂ levels and redox-status of lipids and proteins, contemporarily enhancing AOA and, likely, sustaining normal activity of GPx. Thus, SkQ1 protects the retina from light-induced oxidative stress and could be employed to suppress oxidative damage of proteins and lipids contributing to AMD.

Indexed as

age-related macular degenerationantioxidant activitydisulfide dimerization of proteinsglutathione peroxidaselight-induced retinal damagemitochondria-targeted antioxidantoxidative stressSkQ1superoxide dismutasevisual arrestin

Identifiers

PMID30577635
PMCPMC6356525
OpenAlexW2906609084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.